SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Business
Marvel Biosciences Corp. Announces Change of Chief Financial Officer
February 1, 2022
 · 
1 min read
PharmaDrug Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer
February 1, 2022
 · 
13 min read
Business
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
February 1, 2022
 · 
4 min read
Business
Systemic Therapeutics Announces the Appointment of Its Executive Team
January 31, 2022
 · 
6 min read
Therma Bright Completes U.S. Clinical Performance Study Subject Recruitment
January 31, 2022
 · 
4 min read
PharmaDrug Announces Initiation of Manufacturing of Cepharanthine (PD-001) For Clinical Programs in Rare Cancers And COVID-19
January 26, 2022
 · 
16 min read
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of Addictions
January 26, 2022
 · 
5 min read
Defence’s Accum(TM)-HPV Vaccine Formulation (AccuVAC-PT009) Activates a 36-Fold Higher Humoral Response Compared to Gardasil-9
January 26, 2022
 · 
4 min read
Drug Development
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson’s Disease
January 25, 2022
 · 
4 min read
Pharm Country
Halberd CEO Letter: 2021 Year-End & 2022 Outlook
January 25, 2022
 · 
8 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us